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Changes In blood flow can alter vasomotion of conduit
arteries . This study examined vasomotor responses to
incremental blood flow induced by papaverine in the
epicardial arteries of 10 patients with angiographkaly
normal coronary arteries (group 1) and in 14 patients
with arterial irregularities (group 2) asin„ quantitative
angiography, and Doppler ultrasound flow velocity mea .
statements . An increase in coronary blood flow of 384 .3 u
32.8% (p < 0.001) In group I patients was associated
with dilation of the proximal coronary artery segment and
a 23.2 t 4.6% increase i cross-sectional area (p < 0 .001).
In contrast, in group 2 patients a similar increase in
coronary blood flow of 339 .3 t 18.7% (p < 0.001) was
associated with mixed responses and a modest net con
.
strietlon in cross-sootlonal area of -7 .4 x 2.8% (p < 0.05) .
The dilation response to nitroglycerin was Intac i group
The vasomotion of epicardial coronary arteries in humans is
of interest in relation to the causes of transient myocardial
ischemia . The pattern of dilation of normal coronary arteries
and paradoxic constriction of atherosclerotic arteries has
been observed doing common stimuli for ischemia such as
physical exercise (1,2) and cold pressor testing (3). Although
these stimuli are important in the pathophysiology of ische-
mia during everyday life, their mechanisms are difficult to
interpret in light of simuliareous changes in multiple varia-
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.7 t 4.2%, p < 0.001) and in group 2 (26.4 s 3.2%,
p < 0.001) .
In five patients from group I acetylcholie, an eWothe-
lium-dependent dilator, produced an Increase i crow
sectional area of 20 .7 ± 4.6% (p < 0.05) that paralleled the
response to an Increase w low in the same segment (a
24.3 ± 6 .1% increase in crss-sectional area, p < 0
.05).
Five group 3 patients demonstrated a vasocontrktor
re-
sponse, to acetylcholine is -22
.8 t 3.4% decrease in
cross-sectional area, p < 0.05) together with ma impaired
dilation response to Incremental flow (a -6 .4 ± 3.2%
decrease in
cross-sectional area). Than, the normal flaw-
mediated dilation of coronary arteries is toot in atherasek-
rosts and this impairment may be doe to endothelial cell
vasodilator dysrunetion .
(J Am Call Cordial 1990;16:349-56)
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. such as bean rate, blood pressure . coronary blood flow
and the activation of the sympathetic nervous system.
The large epicardial arteries must accommodate changes
in coronary blood flow
. With the aim of investigating this
important function, this study examined the vasomotion
of
epicardial coronary arteries under conditions of increasing
blood flow
. This condition was ofparticular interest because
increasin
blood flow results in endothelium-dependent re-
laxation or the conduit arteries in animals
(4-6) and in
augiographically smooth coronary arteries in humans (7).
The present study describes the responses of angiographi-
cally normal and atherosclerotic coronary arteries to in-
creases in blood flow produced by papaverine, a dilator of
resistance vessels. To further define the mechanisms of this
response. the same segments of the normal and atheroscle-
rotic coronary arteries examined with increased flow wen .
also studied with acetylcholine, an endothelium-dependent
vasodilator- to test the hypothesis that flow-mediated dila-
tion in humans is endothelium dependeni and that the loss of
0775-1o97/9Usn.50
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this reaction in patients with atherosclerosis is due to dys-
function of the endothelium .
Methods
Patient classification . Twenty-four patients undergoing
diagnostic cardiac catheterization were studied . Patient clas-
sification was based on the extent of atherosclerosis on the
diagnostic angiogram before initiation of the experimental
protocol.
Group 1 . Normal control group . Ten patients had angio-
graphically normal, smooth coronary arteries throughout the
coronary system with no luminal irregularities in the study or
nonstudy vessels. All of these patients had atypical chest
pain and normal exercise tolerance test results . Seven pa-
tients were women and three were men with ages ranging
from 39 to 63 years (mean 49.8).
Group 2 . Patients with atherosclerosis . Fourteen pa-
tients were studied who had angiographic luminal irregular-
ities consistent with coronary atherosclerosis . None of the
patients bad a focal stenosis m50% in the study vessel to
avoid the confounding effect of a flow-limiting stenosis. Nine
patients had a stenosis of >50% diameter narrowing in a
nonstudy vessel . These patients had chest pain and abnor-
mal exercise tolerance test results . Five patients had luminal
irregularities and no stenosis >50% diameter narrowing in
the nonstudy vessel . These five patients had nondiagnostic
exercise test results . Four patients were women and 10 were
men; their ages ranged from 39 to 72 years (mean 55 .1) (p =
NS compared with group 1). One patient carried a diagnosis
of variant angina but had had normal results on a previous
ergonovine study
. Patients with unstable angina, myocardial
infarction, vatvular heart disease, left ventricular hypertro-
phy or heart failure were excluded
.
Written informed consent was obtained from all patients
before the diagnostic angiogram in accordance with guide-
lines established by the Committee for the Protection of
Human Subjects at the Brigham and Women's Hospital and
the Committee to Review Grants for Clinical Research and
Investigation Involving Human Beings of the University of
Michigan Medical Center .
Study design. Antianginal therapy was discontinued 24 to
72 h before the study began except for the unrestricted use of
sublingual nitroglycerin for up to I h before catheterization
.
Diagnostic left heart catheterization and coronary arte-
riography were performed using a standard percutaneous
femoral approach . After the aiagnostic catheterization was
completed the coronary angiograms were reviewed and
patient classification and study vessel were determined
. An
8F guide catheter was introduced into the left main coronary
artery. Heparin (10,000
U) was administered intravenously.
A 2.5F Dapple
; flow velocity catheter (20 MHz pulsed
Doppler catheter, Millar Instruments) was connected to a
velocimeter (model DC-101, Millar Instruments) and then to
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a photographic multichannel oscillographic recorder (Elec-
tronics for Medicine VR16 and MEICOR, Siemens) to
display mean and phasic velocity signals . Before placement
in the guide catheter, the Doppler catheter was zeroed and
calibrated on a 0 to 40 cm/s scale . The Doppler flow velocity
catheter was positioned through the guide catheter over an
0.035 cm (0 .014 in .) guide wire into the midportion of the left
anterior descending or left circumflex artery . The Doppler
flow velocity catheter was placed in the center of the vessel,
the guide wire was removed and a stable flow velocity signal
with minimal noise was obtained . Before beginning the
experimental protocol the position of the Doppler flow
velocity catheter and the range gate control were adjusted to
optimize the audio flow velocity signal and the phasic flow
velocity waveform. The Doppler catheter position and the
range gate control were not changed after this . The position
of the Doppler flow velocity catheter was checked frequently
through the protocol .
The experimental protocol was then performed. After
control conditions were established, papaverine (12 mg) was
infused as a bolus through the Doppler flow velocity catheter
(8). Angiography was performed at the peak increase in
coronary blood flow velocity between 90 and 120 s after the
bolus injection
. A 5 min recovery period was allowed . A
steady state intracoronary infusion of nitroglycerin (50 pg)
was administered through the Doppler flow velocity catheter
over 4 min to test smooth muscle dilator function (9) .
Heart rate and mean and phasic arterial pressure were
measured
continuously. Serial angiograms in orthogonal
views of the study vessel with nonionic contrast medium
were performed in the control period, after the papaverine
dose, after the recontrol period and after intracoronary
nitroglycerin infusion. Continuous measurements of coro-
nary blood flow velocity were recorded from the Doppler
flow velocity catheter .
The coronary artery segment proximal to this catheter
was analyzed to study the effects of increasing blood flow
alone on coronary artery diameter in contrast to the com-
bined effects of blood flow and papaverine (Fig . I). The last
five consecutive patients in each group underwent combined
papaverine and acetylcholine study . In these patients, after
the serial papaverine infusion and reestablishment of recon-
trol conditions, the Doppler flow velocity catheter was
pulled back to the same proximal segment that was analyzed
for the effects of increasing blood flow (Fig. 1). Serial
infusions of intracoronary acetylcholine were delivered
through the Doppler catheter to this proximal segment so
that the same segment could be analyzed for the response to
increasing blood flow and to acetylcholine . Two-minute
infusions (0
.8 ml/min) were used to deliver increasing doses
of acetylcholine to achieve estimated final intracoronary
blood concentrations in the proximal segment of 10 -r and
10 -6 mel/liter (10) . Coronary angiograms were obtained and
coronary flow velocity, electrocardiogram, heart rate and
JACC Vol. 16. Na . 2
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Figure 1. Schematic drawing of placement of the Doppler flow
velocity catheter (solid black line) within the left anterior descending
coronary artery. Papaverine was infused through the distal port of
the Doppler flow velocity catheter. A segment proximal to the
papaverine infusion was analyzed for coronary vasomotion
. For the
subsequent acetylcholine studies . the Doppler flow velocity catheter
was withdrawn proximal to the previously analyzed coronary artery
segment and acetylcholine was infused through the Doppler cathe-
ter
. The vasomotor response to acetylcholine was analyzed in the
sane segment as previously analyzed for papaverine .
blood pressure were measured at the end of each 2 min
infusion. The final coronary blood concentrations of acetyl-
choline were estimated with the assumption that blood flow
in the left anterior and left circumflex arteries was 80 ml/min
(I1) . A second recontrol period was established and followed
by intracorunory infusion of nitroglycerin, as described
previously.
Quantitative coronary angiography . Quantitative coro-
nary angiography was performed by a previously described
and validated technique (12) . Nonionic contrast medium was
injected into the left coronary artery at a rate of 5 ml/s to a
total of 8 or 9 ml with a Medrad power injector to optimize
the quality and reproducibility of the opacification (13) .
Angiograms were obtained while the patients held their
breath to avoid the possible effects of respiration . A biplane
system was used to allow two image intensifiers to be
positioned so that the center of each field of view was in line
with a single position in space (isocentzr). The coronary
artery under study was placed in isocenter . A segment of the
coronary artery 2 to 3 cm proximal to the Doppler flow
velocity catheter that was free of side branches or vessel
NABEL ET AL .
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overlap was analyzed at end-diastole (12). The some segment
was analyzed after each control condition and drug infusion
.
The length of the segment analyzed was 6 .4 ± 0 .2 mm. The
inter- and intraobserver variability of coronary artery diam-
eter measurements using this validated system is low (r =
0
.95 and r = 0
.92, respectively) (14,15) .
Estimates of changes in coronary blood flow . Estimates of
coronary blood flow IQ) were made from measurements of
mean coronary flow velocity (V) and vessel cross-sectional
area (CSA):
0mVuCSA
Cross-ssv rionoi area was determined from measurements
of coronary artery diameter in the region studied from
orthogonal views, assuming an elliptic model:
(DI xD2)xn
CSA =	
4
where 91 = coronary artery diameter in the anteroposterior
projection and D2 = coronary artery diameter in the lateral
pmJection .
Statistical analysis . Ail data are expressed as mean values
x SE . Statistical comparisons were made by two-tailed
analysis
of variance and level of
significance was determined
by Fisher's exact t test . The difference in directional re-
sponse of cross-sectional area and blood flow between
groups I and 2 was tested by unpaired t test . Statistical
significance was assumed if the null hypothesis could be
rejected at the 0.05 probability (p) level .
Results
Nemodynumics (Tattle 1)
. There were no significant
changes in heart rate and systolic or diastolic blood pressure
after the infusion of papaverine or acetylcholine compared
with control conditions in either group I (normal artery) or
group 2 (atherosclerotic artery). A minor decrease in systolic
blood pressure (p < 0.05) was observed after the intracoro-
nary administration of nitroglycerin in both groups .
Coronary blood flow
. In patients with normal coronary
arteries (group I), papaverine produced an increase in car-
Table 1 . Hemodynamic Responses to Infusions of Papaverine . Acetylcholine and Nitroglycerin
	p < 0.05. ACh = acetylcholine : C = conwl : D = diastolic : NTG = nitroglycenn: S - sysld..
C.
NP-mw
112 at C .
ACh
110" nohliterl
C, NT5 (50 pill
Normal arteries Igroup I)
Blood pressure ISMD) Imm Hg) 118 x 7178 x 3 115 2 6175 v 3
115 2 6,77 2 3 117 x 677 x 3 116 5177 x 3 113 x6•05 x3
Hran rate lbnerc/minl
74 '_ 3 75 -- 2 75 x 3 75 x 2 73 - 3
75 S 3
Alhrmsclerofic arteries (group 2)
Blood prasum(SID) (mm Hg) 110 _ 3176 x 3 110 ± 3177 - 3
111 x 3177 x 3 110x3/77 ± 3 110x3177 ! 3 106 a 2'r15 s 3
Heart rate Ibeatslminl
76 ± 4 76 , a 76 - 4 76t 4 76 2 4
80
2
4
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Flgrre 2. Lnerease in coronary blood now (A) produced by papav.
Brine infusion and the associated increase in coronary cross.
sectional area III) in the 10 patients with normal coronary arteries
lgrunp 1). The increment In blood flow produced by papavedne was
associated with a dilation of the coronary artery segment proximal
to the infusion site. *50p < 0.0011
enary blood flow of 384.3 ± 32 .8% (p < 0.001). This
increment in coronary blood flow was associated with dila-
tion of the coronary artery segment proximal to the infusion
site in all 10 palirels; there was a mean increase of 23 .2 t
4 .6%
in cross-sectional area from 8 .2 ± 0.8 mmr (p < 0.001)
(Fig . 2). In all patients the coronary artery segments dilated
ill response to inlracoronary nitroglycerin (50
sac),
with a
31 .7
n
4
.2% increase in cross-sectional area (p < 0.001) .
In the penierra with alherosclerosis (group 2), papaverine
at an equivalent dose produced a similar increase in coro-
nary blood flow of 339
.3 = 18,7% (p-< 0.001) . (n contrast to
the patients with normal coronary arteries, this increment in
blood flow was assvciated with a modest net cuttst :iction of
-7 .4 ± 2
.8% in cress-sectional area from 7 .2 ± 0.9 mm' in
2
ATHEROSCLEROTIC
CORONARY ARTERIES
A
0D
O
0
PA en tNE
27
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PAPAVERInE
12"
Flgnre1
lncrmsing coronary blood flow (A) produced by papaver-
lee infusion and the associated vasomotor response (B) in the 14
patients with atherosclerotic coronary arteries (group 2) . The intro-
melt . itt coronary blood flaw in olhemscle.rotie coronary arteries was
associated with a modest net
constriction
of
em-sectional
area,
with constriction ohserved in I I patients and dilation nh erved in 3
patients . •p < 0 .05 ; . ^. p < 0 .001 .
the proximal segment exposed to an increase in blood flow
(p <0 .05)
. Examination of the data revealed that 11 patients
exhibited constriction and 3 patients exhibited dilation (Fig .
3) . The dilutor response to intraccronary nitroglycerin was
intact in group 2 patients with a 26.4 ± 3.2% increase in
cross-sectional area (p < 0 .001). The spectrum of epicardial
corotery artery response to incremental blood flow is dem-
onstrated in Figure 4, which depicts the dilator response of
normal arteries and the mixed but mostly constrictor te-
sponse of atherosclerotic arteries,
Systemic rerircrdattoa ofpapaverlne was
excluded
as a
cause of dilation in group I patients and mixed responses in
group 2 patients by examining the vasomotor response to
papaverine in the proximal portion of the contmlatcral left
JACC Vol. 16. No. 2
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Figure 4. The range of epicardial coronary artery vasomotor re-
sponse to incremental blood flow in normal coronary arteries Isdid
line) and atherosclerotic coronary arteries (broken line) . Normal
arteries exhibited a dilator response and atherosclerotic arteries had
a mixed but mostly constrictor response to incremental blood flow .
coronary artery. There were no significant changes in cross-
sectional area between control and papaverine infusions in
group 1(5 .4 t 0 .2 to 5 .3 t 0.2 mm') and in group 2 (7.3 ± 0.5
to 7.2 t 0.6 mm') .
Paired responses to papaverine nod acetylcholine. To
study endothelium-dependent vasorelaxation as a mecha-
nism for flow-mediated dilation, five consecutive patients in
each group underwent sequential papaverine and acetylcho-
line study. In group I (normal control) papaverine produced
an increase in coronary blood flow (395
.2 t 27.6%, p < 0.01)
and associated vasoditation of 24 .3 ± 6.1 % from 9.2 t 0 .8
ram"
(p < 0-05) in the proximal coronary artery segment in
all five patients (Fig. 5). Acetylcholine infusion upstream of
the proximal coronary artery segment also produced a
significant dilation of the same segment of 20 .7 ± 4
.6% from
9.2 t 0.8 mm' (p < 0.05) . All proximal artery segments
dilated with intracoronary nitroglycerin by 29 .3 ± 6.9% from
9,2 t 0 .8 mmZ (p < 0 .05) and blood flow increased by 26.2
t
7.4% (p =< 0,05) .
In group 2 an increase in coronary blood flow was
observed after papaverine infusion (322 .6 ± 22.5%, p <
0.01), which was associated with a mean decrease in coro-
nary cross-sectional area in the proximal coronary artery
segment of -6 .4 ± 3 .2% from 8.4 ± 0 .8 man' (p = NS)
compared with control measurements (Fig
. 6). After infusion
of acetylcholine to a concentration of 10 -6 mot/liter, signif-
icant vasoconstriction was observed in the same segment,
-22.8t 3.4%, from 8.4 ± 0.8 m m2 (p < 0.05). Intracoronary
nitroglycerin produced significant dilation in all proximal
coronary segments (20.8 ± 6.7% from 8 .4 ± 0 .8 mm . p <
0 .05) and blood flow increased by 63.8 ± 21 .5% (p < 0 .05).
Intracoronary administration of acetylcholine also pro-
duced an increase in coronary blood flow of 284 .0 t 38 .0%
(p < 0 .01) in group 1 and 191 .2 ± 31 .2% (p < 0.01) in group
2 patients .
NABEL ET AL.
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Figure 5 . Sequential coronary vasomotor response to incremental
blood flow Ipapaverine 12 mg)and intracoronary acetylcholine (10 -6
mePliter) in five patients with normal coronary arteries (group 1) .
Papaverine produced an increase in blood flow and associated
vasodilation in the proximal coronary artery segment . A parallel
vasodilator response was observed with acetylcholine (ACh) infu-
sion . There was no significant difference in coronary cross-sectional
area among C„ C_ and C5 conditions . C, = baseline control ; C, _
repeat control
; C3 = second repeat control
; NTG = nitroglycerin.
'p < 0 .05 .
Discussion
The major findings of this study are that angiographieally
smooth human coronary arteries dilated in response to an
increase in coronary blood flow and to the local administra-
tion of the endothelium-dependent vasodilator acetylcho-
line. This normal mechanism was lost in atherosclerotic
Figure 6. Sequential papeverine and acetylcholine (ACh) study in
five patients with atherosclerotic coronary arteries (group 2) . An
increase in coronary blood 8cw after papaverine infusion was
associated with a mean decrease in coronary cross-sectional area in
the proximal coronary artery segment : after infusion of acetykho-
line (10-6 moUliter), vasoconstriction was also observed . There was
no significant difference in coronary cross-sectional area among C„
C, and C5 conditions . Ab,reviations as in Figure 5. 'p < 0
.05 .
ATHEROSCLEROTIC CORONARY ARTERIES
is
8 - 3n
NORMAL CORONARY APTERIES
ci pw xeoae rn ocM c3
zma 3
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arteries, which failed to dilate in response to both increases
in blood flow and acetylcholine . All corollary segments
dilated in response to the smooth muscle cell relaxing agent
nitroglycerin,
EBdothelial regulation of local blood flow . Experimental
evidence suggests that the endothelium regulates local vessel
tone in response to changes in blood flow (5,6,16,17) . The
mechanism for the flow-induced vasodilation was initially
proposed to be the spreading of a relaxing signal along the
vascular wall, emerging from arterioles in the microcircula-
tion (18,19), but later experiments failed to show inhibition
of this response with transection of the artery distal to the
site of measurements (20,21) . The mechanism remained
unknown until recently when Holtz et al . (4) demonstrated
that endothelial cells act as mediators of flow-dependent
dilation. Mechanical removal of endothelial cells from the
canine femoral artery abolished dilation in response to both
increased blood flow and acetylcholine but not in response to
nitroglycerin, a direct smooth muscle relaxant (16,22) . Use
of the bioassay technique developed for the detection of the
endothelium-derived relaxing factor demonstrated that ace-
tylcholine and blood flow release a relaxing substance with
the same characteristics (23,24).
The mechanisms by which endothelial cells sense and
respond to mechanical forces generated by blood flora are
not completely known. Recordings of calcium ion channel
activity from endothelial cells have revealed that the opening
frequency of these channels increases when the cell mem-
brane is stretched (25) . More recently a potassium-selective,
shear stress-activated channel was identified that is activated
by increasing levels of shear stress and that recovers fully on
cessation of flow (26)
.
These ionic currents may represent
the first step in the transduction ofa mechanical force (blood
flow, shear stress) to a vascular response (flow-mediated
dilation).
Mechanisms of vasodilation. This study provides evi-
dence that incremental blood flow is associated with dilation
in angiographically smooth coronary arteries and, as such, is
a property of normal human arteries . In addition, the dem-
onstration of vasodilation in response to increments in blood
flow and acerylcholine suggests that the release of endothe-
lium-dependent relaxing factor or factors (EDRF) by intact
endothelium may promote vasodilation in human arteries .
These data support previous findings in animal models that
increases in blood flow trigger the release of a substance that
has many characteristics of EDRF (24). Although it is
unlikely that endothelial cells sense chan ;es in volume flow
in an artery, local changes in
shear stress on the endothelium
may stimulate the release of endothelium-dependent relaxing
factors. We have recently demonstrated (27) vasodilation of
angiographicaliy smooth human coronary arteries in re-
sponse to increased shear stress and loss of this response in
atherosclerotic arteries. Alterations in shear stress result in
disruption of endothelial cell morphology in animal models
JACC Vol. 16. No. 2
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that are associated with abnormal Te :ponses to injury and
platelet activation (28
.29)
. Likewise, variations in the direc-
tion and magnitude of shear stress may promote atherogen-
esis (30.31) . Recent data (32) also suggest that increases in
shear stress may stimulate endothelin production by endo-
thelial cells.
Mechanisms of vasoconstriction . In the present study, the
presence of atherosclerosis in human coronary arteries im-
paired flow-mediated dilation . One possible mechanism for
the vasoconstrictor response in atherosclerosis may be en-
dothelial cell dysfunction and a blunting of EDRF release
(33 .34). This conclusion is supported by the findings of
paradoxic vasoconstriction to acetylcholine in the same
atherosclerotic arteries with abnormal responses to in-
creased blood flow . Interestingly, this study suggests that
the precise mechanism of the action of acetylcholine may
also be complex, involving a direct receptor-mediated
(20.34) and an indirect flow-mediated effect (4,5) . Indeed,
intracoronary acetylcholine produced an increase in coro-
nary blood flow in patients with atherosclerotic and normal
coronary arteries, although of smaller magnitude than that
observed with papaverine . Despite the possible multiple
mechanisms of acetylcholine action, this agent has been
shown to induce endothelium-dependent dilation in the
normal artery and loss of dilation with constriction if the
endothelium is dysfunctional (10) . Further evidence of en-
dothelial cell dysfunction in the atherosclerotic segments is
the preserved dilation in response to the nonendothelium-
dependent dilator nitroglycerin.
Thefailare
of
dilation in atherosclerotic coronary arteries
may be
the result of altered catecholamine sensitivity .
Hypersensitivity of vascular smooth muscle in the region of
an atherosclerotic plaque may also produce enhanced vaso-
constriction (33) . Several investigators (35-37) have reported
impairment of endothelium-dependent relaxation in animal
vessels with diet-induced atherosclerosis . Many substances
that elicit the release of EDRF, such as serotonin, norepi-
nephrine, vasopressin and others, also exert a direct vaso-
constrictor effect on vascular smooth muscle (35,38). Al-
though the release of EDRF normally modulates the
constrictor action of these compounds, in the setting of
atherosclerosis these neurohumoral agents could produce
exaggerated vascular constriction because of an unopposed
effect on the smooth muscle. It is unlikely that increased
catecholamines produced the vasoconstrictor response ob-
served in atherosclerotic vessels in this study because nei-
ther papaverine nor acetylcholine produced a change in
heart rate or blood pressure .
Limitations . Although a variety of pharmacologic and
physiologic stimuli are capable of promoting an increase in
coronary blood flow, papaverine was chosen for this study
because it is a relativeiy selective dilator of resistance
vessels and has minimal effects on the large epicardial
coronary arteries (8) . Examination
of
the distal coronary
WC V.I. :a No. :
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artery segment exposed to both incremental blood flow and
papaverine failed to reveal a difference in the change in
coronary luminal area compared with the change induced by
the flow alone in the proximal segment (data not shown) . In
addition, the dilation observed in the proximal segment with
papaverine is probably not due to systemic recirculation of
this agent because similar dilation was not observed in the
contralateral left coronary artery .
The time sequence of dilation after the onset of incremen-
tal flow in human coronary arteries is not known . Previous
studies (5) in closed chest conscious dogs have suggested
that peak dilation occurs approximately 60 s after the induc-
tion of reactive hyperemia in this model
. In the current study
coronary reactions were measured soon after the increase in
coronary blood flow velocity peaked, approximately 90 to
120 s after papaverine injection .
Clinical
implications. Flow-induced vasodilation of epi-
cardial human coronary arteries may contribute to the
normal physiologic response during exercise or other
stresses . The response of normal coronary arteries to exer-
cise or to the cold pressor test is dilation and this response is
replaced by
constriction in atherosclerotic arteries (2,3) .
These physiologic stimuli may exert their effect, in part, by
increasing blood flow and promoting dilation in normal
coronary arteries. Loss of this response in atherosclerotic
and narrowed coronary arteries may have a role in the
genesis of myocardial ischemin. In addition, vasodilation
produced by incremental blood flow may protect the endo-
thelium from injury by keeping shear stress and turbulence
low ; this may possibly reduce the progression of coronary
atherosclerosis (31) .
Conclusions
. This study provides direct evidence of the
failure of an adaptive mechanism, such as endothelium-
dependent dilation in response to increases in blood flow, in
patients with coronary atherosclerosis . This pathogenic
mechanism clarifies at least one functional component of
atherosclerotic stenoses that act intermittently to disturb
coronary blood
flow
and cause myocardial ischemia .
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